Trademark: 90033722
Word
MILLENNIAL SCIENTIFIC
Status Date
Tuesday, August 16, 2022
Registration Number
6817150
Registration Date
Tuesday, August 16, 2022
Filing Date
Thursday, July 2, 2020
Published for Opposition
Tuesday, May 31, 2022
9 Pharmaceutical and scientific research equipment for use in mass spectrometers; Pressure regulators for chromatography separation and purification columns
1 Antioxidants for use in the manufacture of pharmaceuticals; Biometallic compounds for use in the manufacture of pharmaceutical preparations; Chemical additives for use in the manufacture of pharmaceuticals; Dendrimer-based polymers for use in the manufacture of capsules for pharmaceuticals; Diamond molecules and derivatives for use in nanotechnology, microelectronics, optics, and pharmaceuticals; Emollient used as an ingredient in the manufacture of cosmetics, toiletries, and pharmaceuticals; Perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; Phenothiazine for use as a pharmaceutical intermediate; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Polyvinyl alcohol soluble films for use in the manufacture of delivery agents for pharmaceuticals, breath freshener, vitamins, and candy; Preservatives for use in the pharmaceutical industry; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Vitamins for use in the manufacture of pharmaceuticals
42 Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Conducting early evaluations in the field of new pharmaceuticals; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Aug 16, 2022
Notice Of Registration Confirmation Emailed
Aug 16, 2022
Registered-Principal Register
May 31, 2022
Official Gazette Publication Confirmation E-Mailed
May 31, 2022
Published For Opposition
May 11, 2022
Notification Of Notice Of Publication E-Mailed
Apr 28, 2022
Approved For Pub - Principal Register
Apr 28, 2022
Teas/Email Correspondence Entered
Apr 28, 2022
Correspondence Received In Law Office
Apr 26, 2022
Assigned To Lie
Apr 19, 2022
Teas Request For Reconsideration Received
Apr 18, 2022
Teas/Email Correspondence Entered
Apr 18, 2022
Correspondence Received In Law Office
Apr 18, 2022
Teas Request For Reconsideration Received
Feb 24, 2022
Notification Of Subsequent Final Emailed
Feb 24, 2022
Continuation Of Final Refusal E-Mailed
Feb 24, 2022
Action Continuing A Final - Completed
Feb 23, 2022
Teas/Email Correspondence Entered
Feb 22, 2022
Correspondence Received In Law Office
Feb 22, 2022
Teas Request For Reconsideration Received
Aug 23, 2021
Notification Of Final Refusal Emailed
Aug 23, 2021
Final Refusal E-Mailed
Aug 23, 2021
Final Refusal Written
Aug 13, 2021
Teas/Email Correspondence Entered
Aug 13, 2021
Correspondence Received In Law Office
Aug 11, 2021
Assigned To Lie
Aug 6, 2021
Teas Response To Office Action Received
Jun 25, 2021
Notification Of Non-Final Action E-Mailed
Jun 25, 2021
Non-Final Action E-Mailed
Jun 25, 2021
Non-Final Action Written
Jun 16, 2021
Notice Of Revival - E-Mailed
Jun 15, 2021
Petition To Revive-Granted
Jun 15, 2021
Teas Petition To Revive Received
Apr 20, 2021
Abandonment Notice E-Mailed - Failure To Respond
Apr 20, 2021
Abandonment - Failure To Respond Or Late Response
Oct 7, 2020
Notification Of Non-Final Action E-Mailed
Oct 7, 2020
Non-Final Action E-Mailed
Oct 7, 2020
Non-Final Action Written
Oct 7, 2020
Assigned To Examiner
Sep 30, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 30, 2020
Teas Change Of Correspondence Received
Sep 30, 2020
Teas Change Of Owner Address Received
Jul 30, 2020
New Application Office Supplied Data Entered In Tram
Jul 6, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
